dihexa cognitive enhancement 2019 chemically induced Brain peptides in Alzheimer's disease - pathophysiology and therapeutic advances | Cell and Tissue Research Chronic hypoxia leads to cognitive
Description
Type 2 Diabetes Focus Tirzepatide Tirzepatide has 5 SURPASS T2D trials, FDA approval for diabetes (Mounjaro), and demonstrated superiority over semaglutide in SURPASS-2
Here's how it works, the benefits, and how it's used
Serious side effects are rare but will be closely monitored
Neuroprotective effects in cell culture are suggestive but common among many peptides and small molecules
